MOMA Therapeutics
PrivateLast Round
Series B
May 10, 2022
Total Funding Raised
$236M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MOMA Therapeutics is a biotechnology company that discovers and develops precision medicines by targeting molecular machines that drive human disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOMA Therapeutics Comparables
Compare MOMA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Relay Therapeutics | 81% | |
| Foghorn Therapeutics | 78% | |
| Bayer AG | 77% | |
MOMA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 10, 2022 | ||||
| Series A | Apr 15, 2020 |
Key People
Founding team and executive leadership
MOMA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| LifeSci Venture Partners | Series B |
| Creacion Ventures | Series B, Series A |
| Cormorant Asset Management | Series B, Series A |
| Goldman Sachs Asset Management Private Equity | Series B |
| Invus Opportunities | Series B |
| Alexandria Venture Investments | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 42% MoM, reaching 2K.
- Apr 25, 2025
Three presentations scheduled for the 2025 AACR Annual Meeting in Chicago.
MOMA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MOMA Therapeutics's valuation, stock price, and market status.